Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.

Arjun GuptaAnnette E HayMichael CrumpMarina S DjurfeldtLiting ZhuMatthew C CheungLois E ShepherdBingshu E ChenChristopher M Booth

Published in: The oncologist (2023)

Measures of time use, such as contact days, can be extracted from RCTs. In LY.12, despite comparable oncologic outcomes, GDP was associated with fewer contact days. Such information can guide decision-making for patients with hematological cancers, who already face significant healthcare contact.

Keyphrases

healthcare
decision making
clinical trial
squamous cell carcinoma
type diabetes
metabolic syndrome
health information
prostate cancer
health insurance
adipose tissue
minimally invasive